bilobalide has been researched along with Atherogenesis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, BJ; Cho, HJ; Choi, SH; Jang, HC; Kang, SM; Kim, HS; Kim, M; Kim, YB; Lim, S; Park, HS; Park, KS; Shin, H; Yoon, JW | 1 |
1 other study(ies) available for bilobalide and Atherogenesis
Article | Year |
---|---|
EGb761, a Ginkgo biloba extract, is effective against atherosclerosis in vitro, and in a rat model of type 2 diabetes.
Topics: Animals; Apoptosis; Atherosclerosis; Caspase 3; Cell Adhesion; Cell Adhesion Molecules; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclopentanes; Diabetes Mellitus, Type 2; Disease Models, Animal; Furans; Ginkgo biloba; Ginkgolides; Humans; Immunoblotting; Kaempferols; Male; Muscle, Smooth, Vascular; Plant Extracts; Quercetin; Rats; Rats, Inbred OLETF; Reverse Transcriptase Polymerase Chain Reaction; Tunica Intima; U937 Cells | 2011 |